NO20084010L - Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav - Google Patents

Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav

Info

Publication number
NO20084010L
NO20084010L NO20084010A NO20084010A NO20084010L NO 20084010 L NO20084010 L NO 20084010L NO 20084010 A NO20084010 A NO 20084010A NO 20084010 A NO20084010 A NO 20084010A NO 20084010 L NO20084010 L NO 20084010L
Authority
NO
Norway
Prior art keywords
chlorohydrate
preparation
shows
following
crystal form
Prior art date
Application number
NO20084010A
Other languages
English (en)
Norwegian (no)
Inventor
Hugues Bienayme
Jacques Ferte
Original Assignee
Urogene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogene filed Critical Urogene
Publication of NO20084010L publication Critical patent/NO20084010L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20084010A 2006-02-20 2008-09-19 Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav NO20084010L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0601468A FR2897614B1 (fr) 2006-02-20 2006-02-20 Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations
US78715706P 2006-03-30 2006-03-30
PCT/IB2007/001456 WO2007096777A2 (en) 2006-02-20 2007-02-20 Crystal form of besipirdine chlorhydrate, process preparation and use thereof

Publications (1)

Publication Number Publication Date
NO20084010L true NO20084010L (no) 2008-11-19

Family

ID=37309765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084010A NO20084010L (no) 2006-02-20 2008-09-19 Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav

Country Status (16)

Country Link
US (1) US20090048304A1 (pt)
EP (1) EP1996575A2 (pt)
JP (1) JP2009527544A (pt)
KR (1) KR20080106232A (pt)
CN (1) CN101384584A (pt)
AU (1) AU2007219157A1 (pt)
BR (1) BRPI0707997A2 (pt)
CA (1) CA2642687A1 (pt)
FR (1) FR2897614B1 (pt)
IL (1) IL193191A0 (pt)
MA (1) MA30220B1 (pt)
MX (1) MX2008010659A (pt)
NO (1) NO20084010L (pt)
RU (1) RU2008133759A (pt)
WO (1) WO2007096777A2 (pt)
ZA (1) ZA200806876B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2925355T3 (es) * 2017-07-03 2022-10-17 Shandong Danhong Pharmaceutical Co Ltd Forma cristalina y forma amorfa de clorhidrato análogo de dezocina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
PT840609E (pt) * 1995-07-27 2002-10-31 Aventis Pharma Inc Utilizacao de n-(pirrol-1-il)-pirimidinas insubstituidas e substituidas como agentes anticonvulsivos
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos

Also Published As

Publication number Publication date
ZA200806876B (en) 2009-10-28
US20090048304A1 (en) 2009-02-19
MA30220B1 (fr) 2009-02-02
CA2642687A1 (en) 2007-08-30
FR2897614B1 (fr) 2008-05-23
MX2008010659A (es) 2008-09-01
EP1996575A2 (en) 2008-12-03
CN101384584A (zh) 2009-03-11
WO2007096777A3 (en) 2008-01-17
RU2008133759A (ru) 2010-03-27
KR20080106232A (ko) 2008-12-04
AU2007219157A1 (en) 2007-08-30
JP2009527544A (ja) 2009-07-30
WO2007096777A2 (en) 2007-08-30
BRPI0707997A2 (pt) 2011-05-17
IL193191A0 (en) 2009-08-03
FR2897614A1 (fr) 2007-08-24

Similar Documents

Publication Publication Date Title
WO2006122186A3 (en) 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
TW200800963A (en) Chemical compounds
SI1853602T1 (sl) Kemične spojine
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
WO2005074607A3 (en) Method of treating hemolytic disease
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
WO2005121097A3 (en) Pyrazole derivatives, compositions containing such compounds and methods of use
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
WO2006104826A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
NO20065946L (no) DPP-IV-inhibitorer
WO2006047288A3 (en) Asymmetric synthesis of dihydrobenzofuran derivatives
NO20060360L (no) Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer
EA200601295A1 (ru) Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20082909L (no) Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene
WO2009121033A3 (en) Substituted nitrogen heterocycles and synthesis and uses thereof
WO2002066035A3 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
EP1623971A4 (en) ASYMMETRIC SYNTHETIC CATALYST BASED ON BRONSTED CHIRAL ACID AND PROCESS FOR ASYMMETRIC SYNTHESIS THEREOF
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
NO20055750L (no) Nye kjemiske forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application